Cargando…

THU360 Hyperglycemic DKA In Patient On Monotherapy With SGLT-2 Inhibitor

Disclosure: S. Ahmed: None. L. Medina Mora: None. A. Sanchez Ruiz: None. L. Poretsky: None. Background: SGLT2 inhibitors have a rare but increasingly reported risk of euglycemic diabetic ketoacidosis. Hyperglycemic diabetic ketoacidosis is not an expected risk of SGLT-2 inhibitors. Clinical Case: 52...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Samihah, Medina Mora, Luis, Sanchez Ruiz, Angelica, Poretsky, Leonid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Diabetes And Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553708/ http://dx.doi.org/10.1210/jendso/bvad114.793

Ejemplares similares

THU247 Characterizing Inpatient Cases Of DKA Precipitated By SGLT2 Inhibitor Use
por: Aslamy, Arianne, et al.
Publicado: (2023)

THU291 Successful Reversal Of Glucose Toxicity After DKA Precipitated By SGLT2 Inhibitor
por: Abdelrahman, Houda, et al.
Publicado: (2023)

Euglycemic DKA Associated With SGLT2 Inhibitors
por: TakallooBakhtiari, Asieh, et al.
Publicado: (2021)

THU380 A Case Of Alpelisib Induced Diabetic Ketoacidosis (Dka) In A Patient With Type 2 Diabetes Mellitus And Rechallenge With SGLT2 Inhibitor
por: Sekar, Vijaykumar, et al.
Publicado: (2023)

THU376 Isotretinoin Related DKA In Type 2 Diabetes
por: Radovanovic, Natasa, et al.
Publicado: (2023)

ODP244 SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges
por: Penna, Laurianne El Musa, et al.
Publicado: (2022)

Precipitation of Euglycemic DKA (euDKA) From the Initiation of SGLT2 Inhibitor (SGLT2i) and 0-Carb Diet Inpatient
por: Popli, Rakesh, et al.
Publicado: (2021)

THU374 Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab
por: Iqbal, Iqra, et al.
Publicado: (2023)

Euglycemic DKA in Patients on SGLT2 Inhibitor and Potentially Ketotic State
por: Khalifa, Maram, et al.
Publicado: (2021)

THU387 Euglycemic Diabetic Ketoacidosis And SGLT-2 Inhibitor Use
por: Abrahimi, Nora, et al.
Publicado: (2023)

THU379 A Case Of Hyperglycemia With Severe Anion Gap Metabolic Acidosis: HHS Vs DKA
por: Shrivastava, Mashu, et al.
Publicado: (2023)

THU389 Euglycemic Diabetic Ketoacidosis With Prolonged Ketosis Due To SGLT-2 Inhibitor
por: Viera Feliciano, Natalia, et al.
Publicado: (2023)

THU316 Relatively Rare And Increasingly Fatal; A Case Of Euglycemic DKA In A Patient With Gestational Diabetes
por: Dimech, Christina, et al.
Publicado: (2023)

ODP212 Inpatient Euglycemic DKA due to SGLT2 Inhibitors – Lessons From a Case Series and Strategies to Decrease Incidence
por: Burkhardt, Daniel, et al.
Publicado: (2022)

SUN-177 House Of Carbs: The Path To Euglycemic Dka In Patients With Diabetes On Sglt2 Inhibitors
por: Islam, Julie, et al.
Publicado: (2019)

A Case of Euglycemic DKA With SGLT 2 Inhibitor Use- A Diagnostic and Therapeutic Dilemma
por: Nallu, Ravali, et al.
Publicado: (2021)

LBSUN289 Ketonuria — A Possible Early Indicator Of Impending Euglycemic DKA In Setting Of Recent SGLT-2 Inhibitor Use And Acute Stress
por: Arora, Gunjan, et al.
Publicado: (2022)

THU359 A Classical Case Of SGLT-2 Inhibitor Euglycemic Ketoacidosis In A Patient With Glucotoxicity
por: Amankwah, Samuel, et al.
Publicado: (2023)

THU344 Pandemic Effect On National Hospitalizations For Acute Hyperglycemic Complications In Adults With Diabetes
por: Krishnaraju, Ellil, et al.
Publicado: (2023)

THU367 Hyperosmolar Hyperglycemic State In A Middle-old Male With Primary Hyperparathyroidism
por: Mandocdoc Dimayuga, Diana Colleen, et al.
Publicado: (2023)

MON-LB123 Diagnosis and Management of Euglycemic DKA in the Setting of SGLT2 Inhibitor Use and Prostate Abscess
por: Rameshkumar, Naveen Sundar
Publicado: (2020)

THU287 Comparison Of Renal Protective Effects Between SGLT2 Inhibitors And DPP4 Inhibitors In Real-World Clinical Practice
por: Park, Hyeong-Kyu, et al.
Publicado: (2023)

THU282 Improved Fournier’s Gangrene Outcomes With Prior SGLT2i Or Metformin Usage
por: Venugopal, Sharini, et al.
Publicado: (2023)

ODP165 Atypical DKA? Think Cannabis!
por: Albashaireh, Arwa, et al.
Publicado: (2022)

THU345 SGLT2 Inhibitors Reduce Mortality In Patients With Acute Myocardial Infarction And Percutaneous Coronary Intervention: A Systematic Review And Meta-analysis
por: Goncalves Ribeiro, Sandro Augusto, et al.
Publicado: (2023)

PSUN240 A Case of Euglycemic DKA in Pregnancy
por: Grigoryan, Seda, et al.
Publicado: (2022)

SAT058 Diabetes Complicated By DKA, Mucormycosis And Covid-19
por: Gordon, Ashley
Publicado: (2023)

PSUN251 Euglycemic DKA In A Patient Undergoing Major Surgery
por: Dapas, Natalie, et al.
Publicado: (2022)

THU298 Effect Of SGLT2 Inhibition On Metabolic, Cardiac And Renal Outcomes In Heart Transplant Recipients (EMPA-HTx study): Protocol And Study Design
por: Raven, Lisa M, et al.
Publicado: (2023)

FRI642 The Effect Of Early Basal Insulin Administration On Diabetic Ketoacidosis (DKA) Management
por: Al-Marsumi, Hadeel, et al.
Publicado: (2023)

LBODP057 Association Between DKA And Live Abscess: Results From The National Inpatient Sample
por: Muammar, Ahmad, et al.
Publicado: (2022)

Selecting Patients at Risk of Developing DKA on Gliflozins
por: Maletkovic, Jelena
Publicado: (2021)

ODP230 Outcomes of DKA Based on Hospital Teaching Status: A National Inpatient Sample Analysis
por: Ramirez, Marcelo, et al.
Publicado: (2022)

THU372 Finasteride Induced Hyperglycemia
por: Bose, Vivek, et al.
Publicado: (2023)

SAT036 Chlorthalidone Implicated In The Development Of DKA HHS Overlap In A Patient With Type II Diabetes Mellitus
por: Hilder, Robin T
Publicado: (2023)

THU357 A Case Of Recurrent Insulin-induced Edema In A Pediatric Adolescent Patient
por: Mora Calderon, Guido Jesus, et al.
Publicado: (2023)

MON-638 The WBC Differential in Relation to DKA Severity
por: Alamri, Bader Nasser, et al.
Publicado: (2020)

THU353 Late Onset Of Immune Checkpoint Inhibitor-Related Diabetes After 3 Years
por: Avula, Sreekant, et al.
Publicado: (2023)

ODP242 Safety of SGLT2-Inhibitors in Patients with Multiple Myeloma and Diabetes
por: Shyu, Margaret, et al.
Publicado: (2022)

ODP628 Quality Improvement Project (QIP) On Management Of Diabetic Ketoacidosis (DKA) In Adults In A District General Hospital.
por: Haddad, Aiman, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nbhn7i1nppm5o9l15uaeddiqhc